Gene · 2160
Papers2,705
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 2,705
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrating Mechanisms in Thrombotic Peripheral Arterial Disease. | Pharmaceuticals (Basel) | 2022 | 36422558 | PubTator, text mining | PubMed |
| Novel Antithrombotic Agents in Ischemic Cardiovascular Disease: Progress in the Search for the Optimal Treatment. | J Cardiovasc Dev Dis | 2022 | 36421932 | PubTator, text mining | PubMed |
| Distinction of early complement classical and lectin pathway activation via quantification of C1s/C1-INH and MASP-1/C1-INH complexes using novel ELISAs. | Front Immunol | 2022 | 36420270 | PubTator, text mining | PubMed |
| MS-proteomics provides insight into the host responses towards alginate microspheres. | Mater Today Bio | 2022 | 36420052 | PubTator, text mining | PubMed |
| Prevalence and WGS-based characteristics of MRSA isolates in hospitals in Shanghai, China. | Front Microbiol | 2022 | 36406454 | PubTator, text mining | PubMed |
| Expanding spectrum, intrafamilial diversity, and therapeutic challenges from 15 patients with heterozygous CARD11-associated diseases: A single center experience. | Front Immunol | 2022 | 36405754 | PubTator, text mining | PubMed |
| Proteome-wide Mendelian randomization in global biobank meta-analysis reveals multi-ancestry drug targets for common diseases. | Cell Genom | 2022 | 36388766 | PubTator, text mining | PubMed |
| Factor XI, a potential target for anticoagulation therapy for venous thromboembolism. | Front Cardiovasc Med | 2022 | 36386334 | PubTator, text mining | PubMed |
| The Implication of New Developments in Hemophilia Treatment on Its Laboratory Evaluation. | Cureus | 2022 | 36381757 | PubTator, text mining | PubMed |
| PAD4 and Its Inhibitors in Cancer Progression and Prognosis. | Pharmaceutics | 2022 | 36365233 | PubTator, text mining | PubMed |
| DNA Polymorphisms in Pregnant Women with Sticky Platelet Syndrome. | J Clin Med | 2022 | 36362759 | PubTator, text mining | PubMed |
| Clinical Pharmacology of Factor XI Inhibitors: New Therapeutic Approaches for Prevention of Venous and Arterial Thrombotic Disorders. | J Clin Med | 2022 | 36362541 | PubTator, text mining | PubMed |
| Tissue Factor, Thrombosis, and Chronic Kidney Disease. | Biomedicines | 2022 | 36359257 | PubTator, text mining | PubMed |
| Properdin (factor P) as a new target cleaved by factor XIa: Intrinsic coagulation at the crossroads with inflammation. | Res Pract Thromb Haemost | 2022 | 36349265 | PubTator, text mining | PubMed |
| Cryo-EM structures of coagulation factors. | Res Pract Thromb Haemost | 2022 | 36349261 | PubTator, text mining | PubMed |
| Proteomic analysis identifies a signature of disease severity in the plasma of COVID-19 pneumonia patients associated to neutrophil, platelet and complement activation. | Clin Proteomics | 2022 | 36348270 | PubTator, text mining | PubMed |
| SHR2285, the first selectively oral FXIa inhibitor in China: Safety, tolerability, pharmacokinetics and pharmacodynamics combined with aspirin, clopidogrel or ticagrelor. | Front Pharmacol | 2022 | 36339534 | PubTator, text mining | PubMed |
| Case report: Prenatal diagnosis of fetal intracranial hemorrhage due to compound mutations in the JAM3 gene. | Front Genet | 2022 | 36339007 | PubTator, text mining | PubMed |
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
| Structural insights into the contactin 1 - neurofascin 155 adhesion complex. | Nat Commun | 2022 | 36329006 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2160/papers?page=31